Bioanalysis Zone

Advanced characterization of antibody-drug conjugates by LC-MS (Waters Corporation)


Antibody-drug conjugates (ADCs) are a complex the amalgamation of monoclonal antibodies (mAb) and low-molecular-weight toxins. The combination is often a mAb targeted to cancer, delivering a potent cyotoxin to a specific site or cell. The resulting conjugate is complex and typically heterogeneous, making physical chemical characterization challenging. Liquid chromatography coupled with mass spectrometry (LC-MS), and combined with purposefully designed informatics, are powerful tools for the characterization of proteins including mAbs. At Waters we have placed a focus on LC-MS for ADCs based on cysteine, lysine, and engineered conjugates. An ADC-specific LC-MS characterization workflow is illustrated for intact, sub-unit, and peptide levels.

Click here to download presentation

By John Gebler Waters Coporation


Leave A Comment

Please wait...

Bioanalysis Zone New Investigator Award

Why not start this year by doing something good by nominating an early career scientist for the Bioanalysis Zone New Investigator Award. Complete the details below to register your interest!